[
    {
        "document_title": "bfad7df253_44215_ Unmapped_b847916fd5",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "2021-01-04",
                "evidence": "BMBx on 1/4 showed AML with monocytic differentiation (73% blasts) and he was subsequently started on aza/ven on 1/5. Prelim cytogenetic analysis is normal w/ molectular profile demonstrating DNMT3A R882C 44%, IDH1 R132G 41%, NPM1 Type A mutation 40%, NRAS G13R 40%."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44235_ Unmapped_db4a49c191",
        "mutational_status": {
            "NPM1": {
                "status": "positive",
                "date": "",
                "evidence": "He is NPM1 positive, FLT3 ITD negative, which usually suggests a favorable response to azacitidine/venetoclax."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "negative",
                "date": "",
                "evidence": "He is NPM1 positive, FLT3 ITD negative, which usually suggests a favorable response to azacitidine/venetoclax."
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44242_ Unmapped_91922eeb68",
        "mutational_status": {
            "NPM1": {
                "status": "positive",
                "date": "",
                "evidence": "He is NPM1 positive, FLT3 ITD negative, which usually suggests a favorable response to azacitidine/venetoclax."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "negative",
                "date": "",
                "evidence": "He is NPM1 positive, FLT3 ITD negative, which usually suggests a favorable response to azacitidine/venetoclax."
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44253_ Unmapped_eb1cfb823e",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44266_ Unmapped_926cb6626d",
        "mutational_status": {
            "NPM1": {
                "status": "",
                "date": "",
                "evidence": "We should check an NPM1 with each cycle until he clears."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": "His current cycle will be delayed until he recovers an ANC > 1.0 and platelets > 75."
            }
        }
    },
    {
        "document_title": "bfad7df253_44293_ Unmapped_cef80b2c12",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1  c.860_863dup  p.Trp288Cysfs  40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44321_ Unmapped_405761f58d",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "Variants of Known or Likely Clinical Significance Gene Transcript Predicted Protein VAF (%) DNMT3A c.2644C>T p.Arg882Cys 44 IDH1 c.394C>G p.Arg132Gly 41 NPM1 c.860_863dup p.Trp288Cysfs 40 NRAS c.37G>C p.Gly13Arg 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "negative",
                "date": "2021-04-12",
                "evidence": "His peripheral blood NPM1 was negative on 4/12/21."
            }
        }
    },
    {
        "document_title": "bfad7df253_44333_ Unmapped_9a853be59a",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1  c.860_863dup  p.Trp288Cysfs  40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44333_ Unmapped_608329f890",
        "mutational_status": {
            "NPM1": {
                "status": "negative",
                "date": "5/17/2021",
                "evidence": "NPM1, Quantitative Unknown Negative"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44358_ Unmapped_f7b770e347",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44386_ Unmapped_951d16509e",
        "mutational_status": {
            "NPM1": {
                "status": "negative",
                "date": "2021-07-09",
                "evidence": "7/09/21: C7: Aza/Ven   Aza: 35 mg/m2 x 5 days   Venetoclax 400 mg x 21 day ? 14D   NPM1: Negative   ANC:   ;plts:"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44417_ Unmapped_5cad38c51e",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44447_ Unmapped_d9c084bc4c",
        "mutational_status": {
            "NPM1": {
                "status": "",
                "date": "",
                "evidence": "?? NPM1: 2,210 (blood)"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44483_ Unmapped_75b5ac2e2d",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44515_ Unmapped_55e8e73115",
        "mutational_status": {
            "NPM1": {
                "status": "Negative",
                "date": "2021-03-15",
                "evidence": "3/15/21: C3: Aza/ven Aza: 35 mg/m2 x 5 days Venetoclax 400 mg x 21 days NPM1: Negative"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44543_ Unmapped_eced9a6bc5",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44580_ Unmapped_684dad5895",
        "mutational_status": {
            "NPM1": {
                "status": "",
                "date": "",
                "evidence": "FU on the NPM1 Are you candidate Evusheld? NPM1 patients seem to be doing the best. NPM1 begins to rise months before there is measurable disease."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44581_ Unmapped_5dfcd02ccd",
        "mutational_status": {
            "NPM1": {
                "status": "Negative",
                "date": "1/19/22",
                "evidence": "1/19/22: C13: Aza/ven No delay Aza: 35 mg/m2 x 5 days Venetoclax 400 mg x 5 days NPM1: Negative GCSF 1/12, 1/14, 1/16"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44609_ Unmapped_3c93f311dd",
        "mutational_status": {
            "NPM1": {
                "status": "Negative",
                "date": "2022-02-17",
                "evidence": "Given his negative NPM1, I am assuming this is a treatment effect."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44643_ Unmapped_c3b7d6328d",
        "mutational_status": {
            "NPM1": {
                "status": "negative",
                "date": "2022-03-23",
                "evidence": "Your NPM1 from the marrow is negative."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": "Other mutations present (e.g. TP53): This has a particularly poor prognosis."
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44643_ Unmapped_b9cb5c1ca7",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "Variants of Known or Likely Clinical Significance Gene Transcript Predicted Protein VAF (%) DNMT3A c.2644C>T p.Arg882Cys 44 IDH1 c.394C>G p.Arg132Gly 41 NPM1 c.860_863dup p.Trp288Cysfs 40 NRAS c.37G>C p.Gly13Arg 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44678_ Unmapped_dfd0fb7651",
        "mutational_status": {
            "NPM1": {
                "status": "not mutated",
                "date": "",
                "evidence": "However, this subclone does not have mutations in NPM1 and NRAS."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44721_ Unmapped_980d80da25",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup  p.Trp288Cysfs  40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44836_ Unmapped_5f2a4a782b",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "2022-09-29",
                "evidence": "His myeloid mutation panel at that time showed IDH1 and DNMT3A mutations and loss of NPM1 and NRAS."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_44932_ Unmapped_1b3e7aeb0e",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45042_ Unmapped_3c1cb9a7b7",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "2023-04-26",
                "evidence": "His myeloid mutation panel at that time showed IDH1 and DNMT3A mutations and loss of NPM1 and NRAS."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45140_ Unmapped_bf00c7b2be",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45260_ Unmapped_54f0d94e0f",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": "Variants of Known/Likely Clinical Significance DNMT3A c.2644C>T p.(Arg882Cys) 34.8 % IDH1 c.394C>G p.(Arg132Gly) 31.7 %"
            }
        }
    },
    {
        "document_title": "bfad7df253_45356_ Unmapped_4edd9ffd23",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "2024-03-05",
                "evidence": "His myeloid mutation panel at that time showed IDH1 and DNMT3A mutations and loss of NPM1 and NRAS."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45441_ Unmapped_e23dc321e0",
        "mutational_status": {
            "NPM1": {
                "status": "",
                "date": "",
                "evidence": "NPM1: 2,210 (blood)"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45454_ Unmapped_691cb9e734",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "1/04/21",
                "evidence": "NPM1: 2,210 (blood)"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45454_ Unmapped_8b70ad9ddd",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": "His myeloid mutation panel at that time showed IDH1 and DNMT3A mutations and loss of NPM1 and NRAS."
            }
        }
    },
    {
        "document_title": "bfad7df253_45461_ Unmapped_c5f4390730",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "1/2021",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45467_ Unmapped_7607837e4a",
        "mutational_status": {
            "NPM1": {
                "status": "not detected",
                "date": "06/05/2024",
                "evidence": "The previously reported variants in NPM1, NRAS, and ZRSR2 were not detected to a sensitivity of 3% variant allele fraction (VAF) in this sample (see UJW11-91478, GN56213-Y8657)."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "variant of unknown clinical significance",
                "date": "06/05/2024",
                "evidence": "ASXL1 c.210_212del p.(Leu70del) is an in-frame deletion resulting in loss of a single amino acid. Because the functional significance of this change has not been established, it is classified as an ASCO/AMP/CAP Tier III variant (variant of unknown clinical significance) (8)."
            }
        }
    },
    {
        "document_title": "bfad7df253_45497_ Unmapped_3fd7d9e305",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "1/2021",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45497_ Unmapped_92d53a21e8",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "2023-01-05",
                "evidence": "His myeloid mutation panel at that time showed IDH1 and DNMT3A mutations and loss of NPM1 and NRAS."
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    },
    {
        "document_title": "bfad7df253_45502_ Unmapped_50e33dad41",
        "mutational_status": {
            "NPM1": {
                "status": "mutated",
                "date": "",
                "evidence": "NPM1 c.860_863dup p.Trp288Cysfs 40"
            },
            "TP53": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "FLT3": {
                "status": "",
                "date": "",
                "evidence": ""
            },
            "ASXL1": {
                "status": "",
                "date": "",
                "evidence": ""
            }
        }
    }
]
